Cargando…

Chemotherapeutic Drugs: DNA Damage and Repair in Glioblastoma

Despite improvements in therapeutic strategies, glioblastoma (GB) remains one of the most lethal cancers. The presence of the blood–brain barrier, the infiltrative nature of the tumor and several resistance mechanisms account for the failure of current treatments. Distinct DNA repair pathways can ne...

Descripción completa

Detalles Bibliográficos
Autores principales:	Annovazzi, Laura, Mellai, Marta, Schiffer, Davide
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5483876/ https://www.ncbi.nlm.nih.gov/pubmed/28587121 http://dx.doi.org/10.3390/cancers9060057

Ejemplares similares

The DNA damage/repair cascade in glioblastoma cell lines after chemotherapeutic agent treatment
por: ANNOVAZZI, LAURA, et al.
Publicado: (2015)

Glioblastoma: Microenvironment and Niche Concept
por: Schiffer, Davide, et al.
Publicado: (2018)

Stem Cell Niches in Glioblastoma: A Neuropathological View
por: Schiffer, Davide, et al.
Publicado: (2014)

Antigenic and Genotypic Similarity between Primary Glioblastomas and Their Derived Neurospheres
por: Caldera, Valentina, et al.
Publicado: (2011)

The Microenvironment in Gliomas: Phenotypic Expressions
por: Schiffer, Davide, et al.
Publicado: (2015)

SEL1L SNP rs12435998, a predictor of glioblastoma survival and response to radio-chemotherapy
por: Mellai, Marta, et al.
Publicado: (2015)

Stat3 Expression and Its Correlation with Proliferation and Apoptosis/Autophagy in Gliomas
por: Caldera, Valentina, et al.
Publicado: (2008)

Microglia immunophenotyping in gliomas
por: Annovazzi, Laura, et al.
Publicado: (2018)

Correction: SEL1L SNP rs12435998, a predictor of glioblastoma survival and response to radio-chemotherapy
por: Mellai, Marta, et al.
Publicado: (2018)

Comparison among conventional and advanced MRI, (18)F-FDG PET/CT, phenotype and genotype in glioblastoma
por: Valentini, Maria Consuelo, et al.
Publicado: (2017)

The Significance of Chondroitin Sulfate Proteoglycan 4 (CSPG4) in Human Gliomas
por: Schiffer, Davide, et al.
Publicado: (2018)

Promoter Hypermethylation of the EMP3 Gene in a Series of 229 Human Gliomas
por: Mellai, Marta, et al.
Publicado: (2013)

SEL1L plays a major role in human malignant gliomas
por: Mellai, Marta, et al.
Publicado: (2019)

Chondroitin Sulphate Proteoglycan 4 (NG2/CSPG4) Localization in Low- and High-Grade Gliomas
por: Mellai, Marta, et al.
Publicado: (2020)

Flavonoids Synergistically Enhance the Anti-Glioblastoma Effects of Chemotherapeutic Drugs
por: Zhai, Kevin, et al.
Publicado: (2021)

Astroblastoma: beside being a tumor entity, an occasional phenotype of astrocytic gliomas?
por: Mellai, Marta, et al.
Publicado: (2015)

Hyperthermia enhances the efficacy of chemotherapeutic drugs in heat-sensitive cells through interfering with DNA damage repair
por: Ni, Li-Ping, et al.
Publicado: (2022)

MMSET/WHSC1 enhances DNA damage repair leading to an increase in resistance to chemotherapeutic agents
por: Shah, Mrinal Y., et al.
Publicado: (2016)

Update on Chemotherapeutic Approaches and Management of Bevacizumab Usage for Glioblastoma
por: Funakoshi, Yusuke, et al.
Publicado: (2020)

Targeting the DNA Damage Response to Overcome Cancer Drug Resistance in Glioblastoma
por: Ferri, Alessandra, et al.
Publicado: (2020)

Cooperative effect of chidamide and chemotherapeutic drugs induce apoptosis by DNA damage accumulation and repair defects in acute myeloid leukemia stem and progenitor cells
por: Li, Yin, et al.
Publicado: (2017)

Solid Lipid Nanoparticles Carrying Temozolomide for Melanoma Treatment. Preliminary In Vitro and In Vivo Studies
por: Clemente, Nausicaa, et al.
Publicado: (2018)

The Tale of CHD4 in DNA Damage Response and Chemotherapeutic Response
por: Zhang, Jing, et al.
Publicado: (2019)

Aptamers for DNA Damage and Repair
por: McKeague, Maureen
Publicado: (2017)

Drugging DNA Damage Repair Pathways for Trinucleotide Repeat Expansion Diseases
por: Benn, Caroline L., et al.
Publicado: (2021)

Cks Overexpression Enhances Chemotherapeutic Efficacy by Overriding DNA Damage Checkpoints
por: del Rincón, Sonia V., et al.
Publicado: (2014)

The promise of DNA damage response inhibitors for the treatment of glioblastoma
por: Majd, Nazanin K, et al.
Publicado: (2021)

MicroRNAs in the DNA Damage/Repair Network and Cancer
por: Tessitore, Alessandra, et al.
Publicado: (2014)

Drug–Drug Interactions of Cannabidiol with Standard-of-Care Chemotherapeutics
por: Buchtova, Tereza, et al.
Publicado: (2023)

Chromatin structure and DNA damage repair
por: Dinant, Christoffel, et al.
Publicado: (2008)

The Role of Dicer in DNA Damage Repair
por: Tang, Kai-Fu, et al.
Publicado: (2012)

DNA Damage/Repair Management in Cancers
por: Alhmoud, Jehad F., et al.
Publicado: (2020)

DNA Damage and Repair in Eye Diseases
por: Sohn, Joanna, et al.
Publicado: (2023)

Resolving DNA Damage: Epigenetic Regulation of DNA Repair
por: Karakaidos, Panagiotis, et al.
Publicado: (2020)

Role of chemotherapeutic drugs in immunomodulation of cancer
por: Mukherjee, Oishi, et al.
Publicado: (2023)

Effect of gadolinium-based nanoparticles on nuclear DNA damage and repair in glioblastoma tumor cells
por: Štefančíková, Lenka, et al.
Publicado: (2016)

DNA damage repair kinase DNA‐PK and cGAS synergize to induce cancer‐related inflammation in glioblastoma
por: Taffoni, Clara, et al.
Publicado: (2022)

Bone Marrow Osteoblast Damage by Chemotherapeutic Agents
por: Rellick, Stephanie L., et al.
Publicado: (2012)

Research progress of anti-glioma chemotherapeutic drugs
por: Zhou, Yi-Shu, et al.
Publicado: (2022)

Base Excision Repair of Chemotherapeutically-Induced Alkylated DNA Damage Predominantly Causes Contractions of Expanded GAA Repeats Associated with Friedreich's Ataxia
por: Lai, Yanhao, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_mfn3ugsmqhfehdof29uumlf2rf